Browsing Tag
Arlington Capital Partners
2 posts
TransDigm (NYSE: TDG) to deepen aerospace electronics play with Stellant acquisition
Find out why TransDigm is spending $960M on Stellant Systems and what this means for defense electronics and aftermarket strategy going forward.
Arlington Capital Partners acquires AVS Bio from Charles River Laboratories
Arlington Capital Partners, a US-based private equity firm, has acquired Avian Vaccine Services business from Charles River Laboratories.…